CSI Market
Sign In | Register

Adma Biologics Inc (ADMA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ADMA Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Adma Biologics Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ADMA/balance-sheets
https://api.csimarket.com/api/v1/companies/ADMA/fundamentals
https://api.csimarket.com/api/v1/companies/ADMA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent124.56
Cash & Short-term Investments124.00
Accounts receivable169.22
Inventories266.12
Discontinued Operations0.00
Prepaid Expense And Other Assets Current15.97
Total Current Assets575.86
Equipment/Property/Plant Net110.21
Goodwill net3.53
Intangible Assets0.58
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent42.31
Total Assets732.49
Liabilities
Accounts Payable, Current AC35.66
Accrued Liabilities And Other Liabilities0.00
Long-term Debt, Current Maturities LO4.22
Taxes Payable15.60
Discontinued Operation, Liabilities0.00
Total Current Liabilities95.28
Long-term debt195.86
Total Long-term Debt195.86
Deferred Revenue, Noncurrent DE1.30
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent41.35
Current Portion Of Deferred Revenue-
Total Liabilities293.98
Stockholders' Equity
Common Stock Value0.02
Treasury Stock Value-213.74
Additional Paid In Capital Common Stock680.84
Retained Earnings / Accumulated Deficit-28.62
Other Equity0.00
Common Stockholder's Equity438.51
Total Stockholder's Equity438.51
Liabilities & Stockholder's Equity732.49
4 historic quarters locked

Sign in to unlock the full Adma Biologics Inc balance sheet history.

Sign In Create Free Account

About Adma Biologics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001140361-26-041977

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI